Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam dose comparison versus propofol for postoperative delirium in elderly non-cardiac surgery patients
ChiCTR2400082176Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam mesylate and propofol in postoperative delirium (POD) (3 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Postoperative delirium. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
remimazolam mesylatepropofol
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400082176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082176.